1717 related articles for article (PubMed ID: 12447879)
1. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
2. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
[TBL] [Abstract][Full Text] [Related]
3. Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.
Kuemmerle JF
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G101-10. PubMed ID: 15297258
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
5. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.
Salas TR; Reddy SA; Clifford JL; Davis RJ; Kikuchi A; Lippman SM; Menter DG
J Biol Chem; 2003 Oct; 278(42):41338-46. PubMed ID: 12900420
[TBL] [Abstract][Full Text] [Related]
6. Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3beta and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation.
Nemoto T; Satoh S; Maruta T; Kanai T; Yoshikawa N; Miyazaki S; Yanagita T; Wada A
Neuropharmacology; 2010 Jun; 58(7):1097-108. PubMed ID: 20144629
[TBL] [Abstract][Full Text] [Related]
7. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
[TBL] [Abstract][Full Text] [Related]
8. The effects of clozapine on the GSK-3-mediated signaling pathway.
Kang UG; Seo MS; Roh MS; Kim Y; Yoon SC; Kim YS
FEBS Lett; 2004 Feb; 560(1-3):115-9. PubMed ID: 14988008
[TBL] [Abstract][Full Text] [Related]
9. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
Christian SL; Sims PV; Gold MR
J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
[TBL] [Abstract][Full Text] [Related]
10. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
11. Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.
Mannoury la Cour C; Salles MJ; Pasteau V; Millan MJ
Mol Pharmacol; 2011 Jan; 79(1):91-105. PubMed ID: 20952497
[TBL] [Abstract][Full Text] [Related]
12. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation.
Lee TK; Man K; Ho JW; Sun CK; Ng KT; Wang XH; Wong YC; Ng IO; Xu R; Fan ST
Carcinogenesis; 2004 Dec; 25(12):2397-405. PubMed ID: 15297371
[TBL] [Abstract][Full Text] [Related]
13. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma.
Morrison JA; Gulley ML; Pathmanathan R; Raab-Traub N
Cancer Res; 2004 Aug; 64(15):5251-60. PubMed ID: 15289331
[TBL] [Abstract][Full Text] [Related]
14. Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.
Kirshenboim N; Plotkin B; Shlomo SB; Kaidanovich-Beilin O; Eldar-Finkelman H
J Mol Neurosci; 2004; 24(2):237-45. PubMed ID: 15456937
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
Olianas MC; Dedoni S; Onali P
Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.
Cedazo-Mínguez A; Popescu BO; Blanco-Millán JM; Akterin S; Pei JJ; Winblad B; Cowburn RF
J Neurochem; 2003 Dec; 87(5):1152-64. PubMed ID: 14622095
[TBL] [Abstract][Full Text] [Related]
17. Trophoblast apoptosis is inhibited by hepatocyte growth factor through the Akt and beta-catenin mediated up-regulation of inducible nitric oxide synthase.
Dash PR; Whitley GS; Ayling LJ; Johnstone AP; Cartwright JE
Cell Signal; 2005 May; 17(5):571-80. PubMed ID: 15683732
[TBL] [Abstract][Full Text] [Related]
18. Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning.
Barandon L; Dufourcq P; Costet P; Moreau C; Allières C; Daret D; Dos Santos P; Daniel Lamazière JM; Couffinhal T; Duplàa C
Circ Res; 2005 Jun; 96(12):1299-306. PubMed ID: 15920021
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
